Symlin And How To Market On Montel Williams
During the PhRMA annual meeting March 18, Amylin CEO Ginger Graham took talk show host Montel William's advice to be proactive in working with him: she volunteered to come on his program, "The Montel Williams Show," to talk about the diabetes agent Symlin (pramlintide), which was approved by FDA two days earlier. In the following exchange, transcribed by "The Pink Sheet," Graham and Williams discuss ways to present a balanced message about a new drug. As of March 22, Amylin said it had not yet made any firm plans with Williams to do a program.
You may also be interested in...
The pharmaceutical industry should cooperate with documentary film maker Michael Moore, talk show host Larry King recommended during the Pharmaceutical Research & Manufacturers of America annual meeting March 18 in Washington, D.C
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011